Search results

64 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Fischer on Ebola
West Africa continues to experience a deadly Ebola virus outbreak. In May/June, Dr. William Fischer II, a pulmonologist and critical care physician with the UNC School of Medicine, worked in an isolation area in Guinea as part of a team from Doctors without Borders after being recruited by the World Health Organization. To raise awareness about the crisis, we have gathered a list of his media appearances for your viewing.
Located in Vital Signs / 2014 / July 31
UNC medical students gain invaluable experiences abroad
Through the Office of International Activities at the UNC School of Medicine, approximately one-third of UNC medical students experience international health electives during their time in Chapel Hill. This past summer nearly 50 students traveled abroad to research, teach, and enhance their clinical skills while serving underserved populations. The experiences provided students with invaluable insights and encouraged some to continue to make international work part of their lives and careers. Last week students shared their experiences via the UNC SOM Facebook page. Please take a moment to view this visual recap of where our students went and read what they had to say. And if you haven't already done so, "Like" the UNC School of Medicine on Facebook.
Located in Vital Signs / 2015 / Sept. 3
UNC to Test Therapeutic Vaccine in People Living with HIV
A multidisciplinary research team at the University of North Carolina at Chapel Hill has been awarded more than $5.6 million from the National Institutes of Health (NIH) to test a therapeutic vaccine in people living with HIV.
Located in Vital Signs / 2017 / July 27
Vorinostat Renders Dormant HIV Infection Vulnerable to Clearance
The ability for HIV to hide in the body in a dormant state makes curing the 40 million people living with the virus a challenge. Researchers at the University of North Carolina at Chapel Hill have shown the drug Vorinostat reverses this latency, causing resting CD4 T-cells to express HIV.
Located in Vital Signs / 2017 / Aug. 3
T cells alone are sufficient to establish and maintain HIV infection in the brain
Led by J. Victor Garcia, PhD, UNC researchers report in the Journal of Clinical Investigation that T cells in the brain may be an important HIV reservoir that should be targeted by HIV cure approaches.
Located in News / 2018 / June
UNC Lineberger hosts Malawi delegation
A team of Malawian health and government officials met with UNC health and university leaders, researchers and clinical staff across three days to prepare for the opening of the first dedicated cancer center in Malawi.
Located in News / 2018 / June
UNC Lineberger, King's College London scientists collaborate to accelerate cancer research
Across two days in June, scientists held sessions on breast cancer and immunotherapy research, with a focus on identifying cooperative initiatives and funding opportunities.
Located in News / 2018 / July
UNC research, diabetes expertise featured in video at international conference
The American Diabetes Association featured UNC-Chapel Hill diabetes experts and leaders in a video presented at the ADA's 78th Scientific Sessions this summer.
Located in News / 2018 / July
UNC to Create the Next Generation, Ultra-Long-Acting Antiretroviral Formulations for HIV Treatment and Prevention
New project aims to provide long-lasting HIV treatment and/or protection from a single injection. Angela Wahl, PhD, Rahima Benhabbour, PhD, and Martina Kovarova, PhD, are collaborating to lead the work, which is funded by a $3.8-million NIH grant.
Located in News / 2018 / October
Long-acting injectable implant shows promise for HIV treatment and prevention
The long-acting antiretroviral drug formulation, developed by UNC School of Medicine researchers Rahima Benhabbour, PhD and Martina Kovarova, PhD, is injected under the skin and forms into a solid implant that dissolves slowly to release anti-HIV medication over time.
Located in News / 2018 / October